This opportunity is no longer accepting applications.
grant PAR-21-360

Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)

This grant opportunity invites research applications to gather initial data for testing new treatments for cognitive and psychiatric changes linked to age-related cognitive decline, Alzheimer's disease, and related dementias. It aims to support studies across all stages of these conditions, from pre-symptomatic to severe, and encourages improvements in trial design and methods.

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated …

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Aging

Dates

Opportunity Released: January 10, 2022

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.